Most Effective Treatment For Fibromyalgia Among Least Used Says Report
The National Pain Report recently released the results of its fibromyalgia survey examining treatment effectiveness and other questions. Almost 1,500 people participated. (Please note that the percentages in this table are different from those in the National Pain...
New Hemispherx President Says Getting Ampligen Approval Top Priority
After the FDA nixed its approval for Ampligen and saddled its producer, Hemispherx Biopharma, with paying for a large new trial, it looked like Ampligen was dead and gone. Francis Collin’s promise to increase ME/CFS funding, however, caused a seismic shift in...
Will Ketamine be the Next Big Thing for Pain, Depression (and Fatigue)?
A fibromyalgia doctor just gave the thumbs up to ketamine. So did the past director of the National Institute of Mental Health. They both think ketamine or rather drugs based on it could be the cat’s meow for pain and depression. But ketamine also recently...
Next Gen Opioid Drugs Promise Pain Relief Without Side Effects
Opioid Painkillers Under Attack Opioid based pain drugs have dominated the pain relief marketplace for years but their dominance has more reflected a lack of other options than anything else. They’re quite effective at reducing acute pain but not so good at with...
Fibromyalgia and Chronic Fatigue Syndrome (ME/CFS) Research Center Makes Good
Jarred Younger was lured away from Stanford by a University that wanted to get a lead in an emerging field. By definition emerging fields are not quite there yet…they’re emerging. Picking a winner in the medical field sweepstakes may be a bit like backing...Lives Interrupted Latest Story
Megan
Randolph, United States
Former occupation: Day care worker
$562,824
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
